MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Best supportive care or palliative care for late stage Parkinsonian syndromes?

    S. Lorenzl, C. Richinger, C. Schmotz, G. Nübling (Salzburg, Austria)

    Objective: To ask whether best supportive care might be more suitable for patients with Parkinson's disease (PD) and Parkinsonian syndromes and their family than palliative…
  • 2016 International Congress

    The effect of levodopa-carbidopa intestinal gel on activities of daily living: Results from the observational MONOTREAT study in advanced Parkinson’s disease patients

    R. Krüger, P. Lingor, T. Doskas, J. Henselmans, E.H. Danielsen, O. de Fabregues, A. Stefani, S.C. Sensken, J.C. Parra Riaza, K. Onuk, A. Yegin (Tübingen, Germany)

    Objective: To assess the tolerability and effect of levodopa-carbidopa intestinal gel (LCIG, designated in the United States as carbidopa-levodopa enteral suspension) on activities of daily…
  • 2016 International Congress

    Biseptol a new antiParkinsonian agent?

    K. Karpinska, V. Smolanka (Uzhgorod, Ukraine)

    Objective: To evaluate the possible effect of combined intake of levodopa/carbidopa and trimethoprim/sulfamethoxazole on the duration of ON/OFF periods in a PD patient. Background: Drug…
  • 2016 International Congress

    Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease

    J.L. Adams, R.A. Biemiller, K.L. Andrzejewski, S. Sharma, R.L. Rockhill, B.L. Greco, K.C. Hodgeman, P. Singh, S. Khanuja, T. Simuni, K.M. Biglan (Rochester, NY, USA)

    Objective: To determine the feasibility and value of remote blood pressure (BP) monitoring during a clinical trial of isradipine (a dihydropyridine calcium channel antagonist) in…
  • 2016 International Congress

    Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation

    L.M. Oliveira, R.G. Cury, H.F. Chien, J.G. Santos, M.G. Ghilardi, R.B. Machado, E.T. Fonoff, B.R. Egberto (São Paulo, Brazil)

    Objective: The aim of our study was to evaluate prospectively the changes in motor, nonmotor symptoms (NMS) and quality of life produced by subthalamic deep…
  • 2016 International Congress

    Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?

    M.V. Alvarez, P.M. Grogan (San Antonio, TX, USA)

    Objective: To observe if stimulation of deep brain tissue can improve expression of the mouth in Parkinson's disease patients. Background: Masked facies or hypomimia is…
  • 2016 International Congress

    An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator

    C.S. Kubu, J. Vitek, S.E. Cooper, A. Machado, P.J. Ford (Cleveland, OH, USA)

    Objective: To understand changes in patients' desired control of the DBS stimulator in a consecutive series of subjects who underwent DBS for the treatment of…
  • 2016 International Congress

    Weight changes in PD patients post-DBS: A look at the factors involved

    B. Ahmed, L.B. Almeida, A. Bona, S. De Jesus, D. Martinez-Ramirez, M.S. Okun (Gainesville, FL, USA)

    Objective: To evaluate the factors associated with weight changes in Parkinson's disease (PD) patients after deep brain stimulation (DBS) surgery. Background: DBS is a well-established…
  • 2016 International Congress

    Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

    O.L. Tondiy (Kharkiv, Ukraine)

    Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…
  • 2016 International Congress

    1-year clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes

    E. Shalaeva, B. Janabaev, Q. Matmurotov, U. Kasimov, U. Pulatov, A. Bobabekov, M. Bozorboev (Tashkent, Uzbekistan)

    Objective: To evaluate clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes (T2DM) 1-year after operation due to lower extremity artery disease (LEAD)…
  • « Previous Page
  • 1
  • …
  • 385
  • 386
  • 387
  • 388
  • 389
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley